164 related articles for article (PubMed ID: 30668711)
21. Colorectal cancer screening using the faecal occult blood test (FOBt): a survey of GP attitudes and practices in the UK.
Damery S; Clifford S; Wilson S
BMC Fam Pract; 2010 Mar; 11():20. PubMed ID: 20214769
[TBL] [Abstract][Full Text] [Related]
22. Is esophagogastroduodenoscopy necessary in patients with positive fecal occult blood tests and negative colonoscopy?
Choi JS; Choi JY; Cho HG; Han KJ; Kim HM; Cho JH; Kim YJ
Scand J Gastroenterol; 2013 Jun; 48(6):657-62. PubMed ID: 23713803
[TBL] [Abstract][Full Text] [Related]
23. Understanding of a negative bowel screening result and potential impact on future symptom appraisal and help-seeking behaviour: a focus group study.
Barnett KN; Weller D; Smith S; Orbell S; Vedsted P; Steele RJC; Melia JW; Moss SM; Patnick J; Campbell C
Health Expect; 2017 Aug; 20(4):584-592. PubMed ID: 27414462
[TBL] [Abstract][Full Text] [Related]
24. Long-term risk of colorectal cancer after negative colonoscopy in a Danish gFOBT screening cohort.
Bjerrum A; Andersen O; Fischer A; Lindebjerg J; Lynge E
Int J Cancer; 2017 Aug; 141(3):503-511. PubMed ID: 28463410
[TBL] [Abstract][Full Text] [Related]
25. Ontario's ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program.
Rabeneck L; Tinmouth JM; Paszat LF; Baxter NN; Marrett LD; Ruco A; Lewis N; Gao J
Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):508-15. PubMed ID: 24443406
[TBL] [Abstract][Full Text] [Related]
26. Using CT colonography as a triage technique after a positive faecal occult blood test in colorectal cancer screening.
Liedenbaum MH; van Rijn AF; de Vries AH; Dekker HM; Thomeer M; van Marrewijk CJ; Hol L; Dijkgraaf MG; Fockens P; Bossuyt PM; Dekker E; Stoker J
Gut; 2009 Sep; 58(9):1242-9. PubMed ID: 19625276
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests.
Logan RF; Patnick J; Nickerson C; Coleman L; Rutter MD; von Wagner C;
Gut; 2012 Oct; 61(10):1439-46. PubMed ID: 22156981
[TBL] [Abstract][Full Text] [Related]
28. Patient-reported and doctor-reported symptoms when faecal immunochemical tests are requested in primary care in the diagnosis of colorectal cancer and inflammatory bowel disease: a prospective study.
Högberg C; Karling P; Rutegård J; Lilja M
BMC Fam Pract; 2020 Jul; 21(1):129. PubMed ID: 32611307
[TBL] [Abstract][Full Text] [Related]
29. Performance of immunochemical faecal occult blood test in colorectal cancer screening in average-risk population according to positivity threshold and number of samples.
Guittet L; Bouvier V; Mariotte N; Vallee JP; Levillain R; Tichet J; Launoy G
Int J Cancer; 2009 Sep; 125(5):1127-33. PubMed ID: 19431212
[TBL] [Abstract][Full Text] [Related]
30. Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study.
Högberg C; Karling P; Rutegård J; Lilja M
Scand J Gastroenterol; 2017 Jan; 52(1):69-75. PubMed ID: 27623716
[TBL] [Abstract][Full Text] [Related]
31. Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test.
Turner B; Myers RE; Hyslop T; Hauck WW; Weinberg D; Brigham T; Grana J; Rothermel T; Schlackman N
J Gen Intern Med; 2003 May; 18(5):357-63. PubMed ID: 12795734
[TBL] [Abstract][Full Text] [Related]
32. Sex is a stronger predictor of colorectal adenoma and advanced adenoma than fecal occult blood test.
Ferlitsch M; Heinze G; Salzl P; Britto-Arias M; Waldmann E; Reinhart K; Bannert C; Fasching E; Knoflach P; Weiss W; Trauner M; Ferlitsch A
Med Oncol; 2014 Sep; 31(9):151. PubMed ID: 25115743
[TBL] [Abstract][Full Text] [Related]
33. Effect of faecal occult blood positivity on detection rates and positive predictive value of CT colonography when screening for colorectal neoplasia.
Plumb AA; Taylor SA; Halligan S
Clin Radiol; 2015 Oct; 70(10):1104-9. PubMed ID: 26145187
[TBL] [Abstract][Full Text] [Related]
34. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
Todorov K; Wilson C; Sharplin G; Corsini N
Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
[TBL] [Abstract][Full Text] [Related]
35. Option appraisal of population-based colorectal cancer screening programmes in England.
Tappenden P; Chilcott J; Eggington S; Patnick J; Sakai H; Karnon J
Gut; 2007 May; 56(5):677-84. PubMed ID: 17142648
[TBL] [Abstract][Full Text] [Related]
36. Ethnic variation in colorectal cancer risk following a positive faecal occult blood test in an English bowel cancer screening programme centre.
Padmanabhan H; Widlak M; Nevill A; McKaig B; Brookes M; Veitch A
Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1281-5. PubMed ID: 26267240
[TBL] [Abstract][Full Text] [Related]
37. CT colonography before colonoscopy in subjects with positive faecal occult blood test. Preliminary experience.
Sali L; Falchini M; Della Monica P; Regge D; Bonanomi AG; Castiglione G; Grazzini G; Zappa M; Mungai F; Volpe C; Mascalchi M
Radiol Med; 2010 Dec; 115(8):1267-78. PubMed ID: 20680499
[TBL] [Abstract][Full Text] [Related]
38. Colorectal cancer and adenoma screening using urinary volatile organic compound (VOC) detection: early results from a single-centre bowel screening population (UK BCSP).
Mozdiak E; Wicaksono AN; Covington JA; Arasaradnam RP
Tech Coloproctol; 2019 Apr; 23(4):343-351. PubMed ID: 30989415
[TBL] [Abstract][Full Text] [Related]
39. Switching from guaiac to immunochemical faecal occult blood test increases participation and diagnostic yield of colorectal cancer screening.
Bretagne JF; Piette C; Cosson M; Durand G; Lièvre A
Dig Liver Dis; 2019 Oct; 51(10):1461-1469. PubMed ID: 31151896
[TBL] [Abstract][Full Text] [Related]
40. Different faecal sampling methods alter the acceptability of faecal occult blood testing: a cross sectional community survey.
Ellis RJ; Wilson S; Holder RL; McManus RJ
Eur J Cancer; 2007 Jun; 43(9):1437-44. PubMed ID: 17475476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
